Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto: Schedule Product: Creon Forte. Active Ingredient: Pancreatin 300 mg. Dosage Form: Modified release capsule. NZ Sponsor: Boehringer Ingelheim (NZ) Limited. Manufacturer(s): Solvay Pharmaceuticals GmbH, Neustadt a.Rdge, Germany. Dated this 13th day of September 1999. G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).